A Multicenter, Randomized, Double-Blind, Parallel, Phase 2(2b) Clinical Trial to Compare and Evaluate the Efficacy and Safety of SPC1001 in Patients With Essential Hypertension
Latest Information Update: 19 Feb 2025
At a glance
- Drugs Amlodipine/Candesartan/Indapamide (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Shin Poong Pharmaceutical
Most Recent Events
- 19 Feb 2025 New trial record